全文获取类型
收费全文 | 905篇 |
免费 | 47篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 8篇 |
妇产科学 | 5篇 |
基础医学 | 131篇 |
口腔科学 | 14篇 |
临床医学 | 50篇 |
内科学 | 95篇 |
皮肤病学 | 5篇 |
神经病学 | 226篇 |
特种医学 | 32篇 |
外科学 | 59篇 |
综合类 | 36篇 |
预防医学 | 27篇 |
眼科学 | 6篇 |
药学 | 215篇 |
中国医学 | 6篇 |
肿瘤学 | 45篇 |
出版年
2024年 | 1篇 |
2023年 | 6篇 |
2022年 | 11篇 |
2021年 | 29篇 |
2020年 | 15篇 |
2019年 | 49篇 |
2018年 | 69篇 |
2017年 | 40篇 |
2016年 | 18篇 |
2015年 | 21篇 |
2014年 | 46篇 |
2013年 | 46篇 |
2012年 | 59篇 |
2011年 | 69篇 |
2010年 | 67篇 |
2009年 | 61篇 |
2008年 | 58篇 |
2007年 | 42篇 |
2006年 | 33篇 |
2005年 | 31篇 |
2004年 | 20篇 |
2003年 | 27篇 |
2002年 | 22篇 |
2001年 | 23篇 |
2000年 | 11篇 |
1999年 | 6篇 |
1998年 | 2篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 5篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1987年 | 1篇 |
1985年 | 9篇 |
1984年 | 15篇 |
1983年 | 7篇 |
1982年 | 3篇 |
1981年 | 12篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1976年 | 1篇 |
1975年 | 2篇 |
1973年 | 1篇 |
排序方式: 共有961条查询结果,搜索用时 15 毫秒
71.
Michaela Kress R. Kuner 《Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale》2009,196(1):79-88
In recent years, cannabinoids have emerged as attractive alternatives or supplements to therapy for chronic pain states. However,
in humans the activation of cannabinoid receptors in neurons of the central nervous system is associated with psychotropic
side effects, temporary memory impairment and dependence, which arise via the effects of cannabinoids on forebrain circuits.
For clinical exploitation of the analgesic properties of cannabinoids, a major challenge is to devise strategies that reduce
or abolish their adverse effects on cognitive, affective and motor functions without attenuating their analgesic effects.
The cannabinoid receptor family currently includes two cloned metabotropic receptors: CB1, CB2 and possibly GPR55 which are
distributed widely across many key loci in pain-modulating pathways, including the peripheral terminals of primary afferents.
Modulation of transducer ion channels expressed at nociceptive terminals occurs upon activation of metabotropic cannabinoid
receptors, but direct cannabinoid action on ion channels involved in sensory transduction or regulation of neuron excitability
likely contributes to the peripheral cannabinoid effects. 相似文献
72.
Silvia Rossi Roberto Furlan Valentina De Chiara Alessandra Musella Temistocle Lo Giudice Giorgia Mataluni Francesca Cavasinni Cristina Cantarella Giorgio Bernardi Luca Muzio Alessandro Martorana Gianvito Martino Diego Centonze 《Neurobiology of disease》2009,36(1):51-59
Voluntary exercise is beneficial in models of primarily neurodegenerative disorders. Whether exercise also affects inflammatory neurodegeneration is unknown. In the present study, we evaluated the clinical, synaptic and neuropathological effects of voluntary wheel running in mice with myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. Exercising EAE mice exhibited less severe neurological deficits compared to control EAE animals. The sensitivity of striatal GABA synapses to the stimulation of cannabinoid CB1 receptors was dramatically downregulated following EAE induction, and was rescued by exercise in EAE mice with access to a running wheel. Finally, we found that exercise was able to contrast dendritic spine loss induced by EAE in striatal neurons, although the degree of inflammatory response was similar in the two experimental groups.Our work suggests that life style and experiences can impact the clinical course of inflammatory neurodegenerative diseases by affecting their synaptic bases. 相似文献
73.
Augustin Baulig Seema Singh Alexandre Marchand Roel Schins Robert Barouki Michèle Garlatti Francelyne Marano Armelle Baeza-Squiban 《Toxicology》2009
Particulate matter (PM) is suspected to play a role in environmentally-induced pathologies. Due to its complex composition, the contribution of each PM components to PM-induced biological effects remains unclear. 相似文献
74.
Sara Jane Ward Marisa Rosenberg Linda A. Dykstra Ellen A. Walker 《Drug and alcohol dependence》2009,105(3):248-255
Cannabinoid CB1 antagonists decrease self-administration of palatable food and several abused drugs in animals and modulate extinction of conditioned fear responses. Less is known, however, about whether and how CB1 antagonists might modulate the extinction of appetitive behavior. Therefore, this study examined the effects of the CB1 receptor antagonist rimonabant (SR141716) during extinction of responding maintained either by cocaine or by palatable foods (corn oil or Ensure), as well as responding elicited by stimulus cues that had been paired with the presentation of cocaine (i.e., cue-induced reinstatement) or a prime (presentation of cocaine or food). The effect of rimonabant on high rate responding in water-deprived mice trained to self-administer water was also examined. In mice self-administering cocaine, rimonabant attenuated cue-induced reinstatement of cocaine self-administration, the initial burst of responding during cocaine extinction and responding during spontaneous recovery. In mice self-administering corn oil, rimonabant decreased responding during extinction and also attenuated responding that had been reinstated by a priming presentation of corn oil. Moreover, mice treated with rimonabant required fewer daily sessions to reach criterion for extinction of cocaine-maintained responding than vehicle treated mice. Also, rimonabant had no effect on the rate of operant responding in mice trained to respond for water under an FR5 schedule of reinforcement. Taken together, these data suggest that in addition to attenuating the primary reinforcing effects of both palatable foods and drugs of abuse, CB1 receptor antagonism can attenuate context and cue reactivity during extinction learning and potentially enhance extinction learning in this way. 相似文献
75.
Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats 总被引:1,自引:0,他引:1
Cannabinoids have been reported to sustain self-administration in laboratory animals; however, genetic differences and environmental factors critical in the initiation and retention of such behaviour are yet to be defined. This study investigated the acquisition, maintenance and extinction of self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 (6.25-25 microg/kg/inf) in Long Evans, Lister Hooded and Sprague-Dawley rats under a continuous schedule of reinforcement and two different response-like operanda, nose-poking and lever-pressing. Results showed that Long Evans and Lister Hooded, but not Sprague Dawley, rats acquired and retained stable cannabinoid self-administration behaviour under both modus operandi, as defined by significant differences between responding in the active versus the inactive hole/lever. In rats developing firm self-administration, substitution of saline for WIN 55,212-2 extinguished the responding, supporting the notion that cannabinoids may serve as a positive reinforcer in laboratory animals. Nevertheless, significant differences among strains and responding modalities were observed in the percentage of acquisition, amount of drug intake during maintenance and timing of extinction. In addition, no significant strain differences were found in motor response to WIN 55,212-2 (0.3 and 3.0 mg/kg), thus excluding that strain differences observed during cannabinoid self-administration could be related to different cannabinoid-induced locomotor effects. 相似文献
76.
E. Schlicker J. Timm J. Zentner M. Göthert 《Naunyn-Schmiedeberg's archives of pharmacology》1997,356(5):583-589
We examined the question of whether cannabinoid receptors modulating noradrenaline release are detectable in the brain of
humans and experimental animals. For this purpose, hippocampal slices from humans, guinea-pigs, rats and mice and cerebellar,
cerebrocortical and hypothalamic slices from guinea-pigs were incubated with [3H]noradrenaline and then superfused. Tritium overflow was evoked either electrically (0.3 or 1Hz) or by introduction of Ca2+ ions (1.3μM) into Ca2+-free, K+-rich medium (25μM) containing tetrodotoxin 1μM. Furthermore, the cAMP accumulation stimulated by forskolin 10μM was determined
in guinea-pig hippocampal membranes. We used the following drugs: the cannabinoid receptor agonists (–)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol
(CP-55,940) and R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazin-yl]-(1-naphthalenyl)methanone (WIN 55,212-2), the inactive S(–)-enantiomer of the latter (WIN 55,212-3) and the CB1 receptor antagonist N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide (SR 141716). The electrically evoked tritium overflow from guinea-pig hippocampal slices was reduced by WIN 55,212-2 (pIC30% 6.5) but not affected by WIN 55,212-3 up to 10μM. The concentration-response curve of WIN 55,212-2 was shifted to the right
by SR 141716 (0.032μM) (apparent pA2 8.2), which by itself did not affect the evoked overflow. WIN 55,212-2 1μM also inhibited the Ca2+-evoked tritium overflow in guinea-pig hippocampal slices and the electrically evoked overflow in guinea-pig cerebellar, cerebrocortical
and hypothalamic slices as well as in human hippocampal slices but not in rat and mouse hippocampal slices. SR 141716 (0.32μM)
markedly attenuated the WIN 55,212-2-induced inhibition in guinea-pig and human brain slices. SR 141716 0.32μM by itself increased
the electrically evoked tritium overflow in guinea-pig hippocampal slices but failed to do so in slices from the other brain
regions of the guinea-pig and in human hippocampal slices. The cAMP accumulation stimulated by forskolin was reduced by CP-55,940
and WIN 55,212-2. The concentration-response curve of CP 55,940 was shifted to the right by SR 141716 (0.1μM; apparent pA2 8.3), which by itself did not affect cAMP accumulation. In conclusion, cannabinoid receptors of the CB1 subtype occur in the human hippocampus, where they may contribute to the psychotropic effects of cannabis, and in the guinea-pig
hippocampus, cerebellum, cerebral cortex and hypothalamus. The CB1 receptor in the guinea-pig hippocampus is located presynaptically, is activated by endogenous cannabinoids and may be negatively
coupled to adenylyl cyclase.
Received: 5 June 1997 / Accepted: 6 August 1997 相似文献
77.
本文用CB微核法研究了超高剂量6MVX射线照射人离体血后微核(MN)的剂量效应关系, 见到剂量高至25Gy仍可见双核cB细胞, 在0~10Gy范围内, MN率与照射剂量呈正相关
关系, 并得到拟合较好的回归方程, 有可能打破近30正来生物剂量估算为5 Gy的上限, 使能直接的估算大于5Gy受照者的生物剂量, 摄高了以MN检测作为生物学剂量计的应用价值。10Gy以上, MN串的上升呈平缓的坪趋势, 在10~25Gy范围内虽不能精确的估算剂量, 但片中双核CB细胞的多少, 对判断剂量有—定参考价值。 相似文献
78.
Cannabinoids are known to interact with CB1 and CB2 receptors expressed in the nervous and immune system, respectively, and mediate a wide range of effects, including anti-inflammatory properties. However, cannabinoids that bind CB1 are also psychoactive thereby limiting their clinical use. In this study, we investigated the immunosuppressive properties of JWH-015, a synthetic CB2-selective agonist. We found that JWH-015 triggered apoptosis in thymocytes in vitro and inhibited the proliferative response of T and B cells to mitogens through induction of apoptosis. JWH-015 induced cross-talk between extrinsic and intrinsic pathways of apoptosis involving caspase-8, caspase-9, and caspase-3 as well as loss of mitochondrial membrane potential. Finally, administration of JWH-015 in vivo caused thymic atrophy, apoptosis, and decreased peripheral T cell response to mitogens. Together, this study suggests that CB2-selective agonists, devoid of psychotropic effect, may serve as novel anti-inflammatory/immunosuppressive agents. 相似文献
79.
Résumé Les vanillo?des et les cannabino?des, deux substances extraites respectivement du piment du Chili et du cannabis, sont impliqués
dans la douleur. Nous verrons ici comment la localisation des récepteurs cannabino?des CB1 et CB2 et des récepteurs vanillo?des
VR1 peut apporter des renseignements précieux pour comprendre leu r?le. Les récepteurs VR1 sont localisés dans quatre populations
cellulaires de fibres sensorielles impliquées dans la douleur aigu? et chronique. Un contr?le noradrénergique central de la
nociception à partir du locus coeruleus par les vanillo?des est aussi vraisemblable. Les cannabino?des sont impliqués dans
la modulation de la douleur aigu? ou chronique au niveau spinal par l’intermédiaire de récepteurs CB1 présents sur des afférences
primaires, des interneurones inhibiteurs et des astrocytes. Au niveau supraspinal, les cannabino?des sont impliqués dans les
contr?les monoaminergiques, sérotoninergiques ou noradrénergiques. Ils pourraient jouer un r?le également dans les régulations
centrales du système autonome par la douleur et les aspects psychoaffectifs de la douleur. Les données synthétisées ici suggèrent
aussi l’existence de nouveaux types ou sous-types de récepteurs aussi bien pour les cannabino?des que pour les vanillo?des.
Enfin, la coexistence, au moins régionale, des récepteurs CB1 et VR1 renforce l’hypothèse récente d’une interaction entre
ces deux systèmes.
相似文献
80.
Irwin Goldstein Noel N. Kim Anita H. Clayton Leonard R. DeRogatis Annamaria Giraldi Sharon J. Parish James Pfaus James A. Simon Sheryl A. Kingsberg Cindy Meston Stephen M. Stahl Kim Wallen Roisin Worsley 《Mayo Clinic proceedings. Mayo Clinic》2017,92(1):114-128
The objective of the International Society for the Study of Women's Sexual Health expert consensus panel was to develop a concise, clinically relevant, evidence-based review of the epidemiology, physiology, pathogenesis, diagnosis, and treatment of hypoactive sexual desire disorder (HSDD), a sexual dysfunction affecting approximately 10% of adult women. Etiologic factors include conditions or drugs that decrease brain dopamine, melanocortin, oxytocin, and norepinephrine levels and augment brain serotonin, endocannabinoid, prolactin, and opioid levels. Symptoms include lack or loss of motivation to participate in sexual activity due to absent or decreased spontaneous desire, sexual desire in response to erotic cues or stimulation, or ability to maintain desire or interest through sexual activity for at least 6 months, with accompanying distress. Treatment follows a biopsychosocial model and is guided by history and assessment of symptoms. Sex therapy has been the standard treatment, although there is a paucity of studies assessing efficacy, except for mindfulness-based cognitive behavior therapy. Bupropion and buspirone may be considered off-label treatments for HSDD, despite limited safety and efficacy data. Menopausal women with HSDD may benefit from off-label testosterone treatment, as evidenced by multiple clinical trials reporting some efficacy and short-term safety. Currently, flibanserin is the only Food and Drug Administration–approved medication to treat premenopausal women with generalized acquired HSDD. Based on existing data, we hypothesize that all these therapies alter central inhibitory and excitatory pathways. In conclusion, HSDD significantly affects quality of life in women and can effectively be managed by health care providers with appropriate assessments and individualized treatments. 相似文献